English Overview
Dr. Yassir Javaid will conduct a significant event review (SER) of a hypothetical patient who suffered a cardiovascular event.
Dr. Javaid’s presentation presents a comprehensive patient case while revisiting different guidelines and trials data to answer the question: Was this significant event preventable?
The presentation is pre-recorded and will be in 3 parts; each part is followed with a live discussion/Q&A between Dr. Javaid, Prof. Tofe and moderated by Dr. Rachman.
This Activity for
- Resident / Fellow
- Physician
What I will learn?
Help define/identify the typical T2D primary prevention patient
Reinforce different guidelines and their applicability
Focus on GLP-1 RA CVOTs; specifically, REWIND
Dulaglutide as a treatment option for such patients
Reinforce different guidelines and their applicability
Focus on GLP-1 RA CVOTs; specifically, REWIND
Dulaglutide as a treatment option for such patients
Recorded Programs
Preventing Cardiovascular Events In People With T2D Part 1
Due Date 21/06/2021
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
|
Preventing Cardiovascular events in people with T2D Certificate
Certificate |
Certificate | Free |
VAT 15% Included
